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Purpose: The purpose of this study was to compare the cardiopulmonary morbidity and mortality rates after endovascular
abdominal aortic aneurysm (EAAA) repair with local anesthesia (LA) with intravenous sedation versus general anesthesia
(GA).
Methods: Data from patients who underwent elective infrarenal EAAA repair between June 1996 and October 2000 were
retrospectively reviewed. Patients with two or more Eagle clinical cardiac risk factors were considered to be at increased
risk for a major postoperative cardiac event. Univariate and multivariate analyses for major cardiac and pulmonary
morbidity and mortality rates were analyzed with respect to anesthetic type (GA versus LA), age, size of aneurysm, mean
number of Eagle risk factors, and presence of two or more cardiac risk factors.
Results: Two hundred twenty-nine patients underwent EAAA repair. The GA (158 patients) and LA (71 patients) groups
were significantly different with respect to mean age (73 versus 76 years; P .01) and mean number of cardiac risk factors
per patient (1.2 versus 1.6; P  .002). No difference was seen in the overall cardiopulmonary complication rate (13% for
GA and 19% for LA; P  .3), pulmonary complication rate (3.8% for GA and 7% for LA; P  .3), or cardiopulmonary
mortality rate (3.2% for GA and 2.8% for LA; P  .9). The major cardiac event rate was higher in patients with two or
more Eagle risk factors (22%) versus those patients with one or less Eagle risk factors (3.4%; P < .001), irrespective of
anesthetic type. In analysis of patients with one or less Eagle risk factors, no difference was seen in the major cardiac event
rate by anesthetic type (3% for GA and 5% for LA; P .6). Also, no difference was seen in major cardiac events in patients
with two or more Eagle risk factors by anesthetic type (24% for GA and 22% for LA). On multivariate analysis, the mean
number of Eagle risk factors per patient (P < .0001) and the presence of two or more Eagle risk factors were associated
with major cardiac and cardiopulmonary complications, whereas age, size of AAA, and anesthetic type were not.
Conclusion: No difference exists in overall cardiac and pulmonary morbidity and mortality rates after EAAA repair in
comparison of GA and LA. The presence of two or more preoperative cardiac risk factors significantly increases the risk
of a major postoperative cardiac event. (J Vasc Surg 2002;36:988-91.)
Cardiopulmonary morbidity and mortality rates after
abdominal aortic aneurysm repair remain significant. In a
prospective multicenter trial involving 666 patients who
underwent elective open abdominal aortic aneurysm repair,
the cardiac event rate was 15% and the respiratory failure
rate was 8%.1 Endovascular abdominal aortic aneurysm
repair (EAAA) has been developed in an effort to reduce
the morbidity and mortality associated with open repair.
Despite the less invasive nature of EAAA repair, operative
mortality and cardiac morbidity rates are similar to those of
open repair. In a comparison of open and EAAA repair,
May et al2 showed no difference in the survival rate. Simi-
larly, de Virgilio et al3 noted no difference in the adverse
cardiac event rate or mortality rate in comparing these two
techniques. A recent study showed the feasibility of EAAA
repair with local anesthesia (LA) with intravenous seda-
tion.4 Henretta et al4 noted no operative deaths or cardio-
pulmonary complications in 47 patients who underwent
EAAA repair with LA. The purpose of this study was to
compare the cardiac and pulmonary morbidity and mortal-
ity rates after EAAA repair with LA with intravenous seda-
tion versus general anesthesia (GA).
METHODS
Data from consecutive patients who underwent elective
infrarenal EAAA repair at Harbor-UCLA Medical Center
between June 1996 and October 2000 were reviewed
retrospectively. Clinical preoperative risk factors (age 70
years, diabetes, Q wave on electrocardiogram, angina, and
history of congestive heart failure) as described by Eagle
and colleagues5 were determined for each patient. The
patients were divided into two groups on the basis of
whether their procedures were performed with GA or LA.
For the purpose of analysis, patients were also subdivided
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by the number of Eagle risk factors because previous studies
have shown that patients with two or more Eagle risk
factors are at increased risk for an adverse cardiac event.
GA was the anesthetic of choice in patients in the first 2
years of the study. As comfort with EAAA repair increased
and the feasibility of LA with intravenous sedation became
apparent, a shift was seen towards almost exclusive use of
LA in the latter 2 years of the study. The exception to the
use of LA in the latter 2 years of the study was patient
preference. The final decision as to whether to perform
EAAA repair with LA or GA was at the discretion of the
attending anesthesiologist and surgeon. Patients who be-
gan anesthesia with LA and subsequently underwent con-
version to GA were analyzed in the GA group.
Intravenous sedation was performed by a single anes-
thesiologist for all patients and involved a titration of
midazolam, fentanyl citrate, and propofol. The amount and
depth of sedation varied with the length of the case. The
vast majority of patients were awake enough to control
their own airway and were arousable. Adverse perioperative
events were defined as those that occurred during the index
hospital stay or within 30 days of surgery. Major cardiac
complications included Q wave and non–Q wave myocar-
dial infarction (MI), congestive heart failure (CHF), unsta-
ble angina, and cardiac arrest. MI was defined as an eleva-
tion of the serum creatinine kinase MB isoenzyme level to 5
ng/mL or more and a troponin level of 2 ng/mL or more
or new Q waves or persistent ST segment changes on
electrocardiogram. CHF was defined as: 1, signs or symp-
toms of pulmonary congestion (shortness of breath or
rales); 2, signs or symptoms of new left or right ventricular
failure (cardiomegaly, jugular venous distention, peripheral
edema); or 3, abnormal chest radiographic findings (vascu-
lar redistribution, interstitial or alveolar edema). Major
dysrhythmias were defined as dysrhythmias that resulted in
hypotension (systolic blood pressure 90 mm Hg) or
those that necessitated monitoring in the intensive care unit
(ICU). Cardiac arrest and cardiac death were defined as
arrest or death after a cardiac complication. The adverse
cardiac event rate for patients with two or more Eagle risk
factors was analyzed separately from patients at low cardiac
risk (one or less risk factors). Major pulmonary complica-
tions included adult respiratory distress syndrome, pneu-
monia, and respiratory arrest.
Categoric variables were examined for associations with
2 or Fisher exact tests where appropriate. Continuous
variables were compared with the Wilcoxon rank sum test.
A P value of less than .05 was considered statistically
significant. Logistic regression analysis was performed for
cardiac complications, pulmonary complications, com-
bined cardiopulmonary complications, and cardiac death
with the following covariates: age, mean number of Eagle
cardiac risk factors, the presence of two or more Eagle
cardiac risk factors, size of aneurysm, and type of anesthetic
(GA versus LA). All statistical comparisons were performed
with the SAS statistical software package (SAS Institute,
Cary, NC).
RESULTS
Two hundred twenty-nine patients underwent EAAA
repair, 158 patients with GA and 71 patients with LA. Nine
patients (6%) in the GA group needed an adjunctive vascu-
lar procedure (six femoral to femoral crossover bypasses,
three iliac artery exposures with chimney stack) compared
with seven patients (10%) in the LA group (five femoral to
femoral crossover bypasses, two iliofemoral bypasses).
Eleven patients who began anesthesia with LA needed
conversion to GA. The GA and LA groups were signifi-
cantly different with respect to mean age, mean number of
Eagle risk factors per patient, and mean aneurysm size
(Table I). The mean lengths of anesthetic and operative
times were longer for GA. Patients who underwent repair
with GA received more intraoperative fluids. The mean
length of ICU stay was longer for the LA group.
A comparison of cardiopulmonary morbidity and mor-
tality rates is shown in Table II. No difference was seen in
pulmonary events (3.8% GA; 7% LA), major cardiac events
(9% GA; 13% LA), combined cardiopulmonary events (13%
GA; 19% LA), cardiac deaths (3% GA; 0 LA), pulmonary
deaths (0 GA; 2.8% LA), and noncardiac deaths (1.3% GA;
1.5% LA; P  .9).
The major cardiac event rate was 22% for patients with
two or more Eagle risk factors versus only 3.4% for patients
with one or less Eagle risk factors (P  .001). Within the
group of patients with one or less Eagle risk factors, the
major cardiac event rate was 3% with GA versus 5% with LA
(P  .6). In the group of patients with two or more Eagle
risk factors, the major cardiac event rate was again similar
for GA versus LA (24% versus 22%, respectively; P  1.0;
Table III). On multivariate analysis, the mean number of
Eagle risk factors per patient (P .0001) and the presence
of two or more Eagle risk factors (P  .0002) were associ-
Table I. Comparison of patients undergoing EAAA
repair with GA versus LA
Factor (mean) GA (n  158) LA (n  71) P value
Age (y) 73.5 76 .01
No. of Eagle risk factors 1.2 1.6 .002
Aneurysm size (mm) 57 53 .02
Anesthetic time (min) 307 271 .01
Operative time (min) 210 180 .02
Intraoperative fluids (mL) 2928 2168 .001
Length of ICU stay (d) 1.9 2.3 .001
Table II. Comparison of morbidity and mortality rates
for patients undergoing EAAA repair with GA versus LA
Complication GA (n  158) LA (n  71) P value
Pulmonary 3.8% 7% .3
Major cardiac 9% 13% .4
Cardiopulmonary 13% 19% .3
Cardiac death 3% 0 .1
Pulmonary death 0 2.8% .1
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ated with major cardiac and cardiopulmonary complica-
tions, whereas age, size of aneurysm, and anesthetic type
were not.
DISCUSSION
This study showed no difference in cardiopulmonary
morbidity and mortality rates in patients who underwent
EAAA repair with GA as compared with LA. Few studies
exist that analyze the efficacy of LA for EAAA repair.4,6
Henretta and associates4 reported no cardiopulmonary
complications in 47 consecutive patients who underwent
EAAA repair with LA. Fifty-five percent of the patients had
evidence of coronary artery disease, which was defined as
angina or previously treated coronary or valvular heart
disease. The number of patients with multiple Eagle cardiac
risk factors was not stated, nor were the definitions of
cardiopulmonary complications. Bettex et al6 similarly re-
ported no cardiopulmonary morbidity or mortality in 91
patients who underwent EAAA repair, of whom 63 had LA.
In this study, the major cardiac event rate was 10% and did
not differ for patients with GA (9%) versus LA (13%). Of
note, our definition of cardiopulmonary complications in-
cluded Q wave and non–Q wave MI, CHF, unstable an-
gina, cardiac arrest, adult respiratory distress syndrome,
pneumonia, and respiratory arrest. Similar to our data, May
and colleagues2 reported a 7.4% rate of major cardiac
complications after EAAA repair, although the type of
anesthetic used was not stated.
Although the finding of equivalent cardiopulmonary
morbidity rates for GA and LA may seem counterintuitive,
other studies that compared local/regional anesthetic and
GA for peripheral vascular surgery have also shown equiv-
alent cardiovascular risks.7-9 In patients who underwent
carotid endarterectomy, Ombrellaro et al10 noted a 0.8%
MI rate with GA versus a 2.1% MI rate with local/regional
anesthesia (P  .35). The overall cardiac complication rate
was 18.3% for GA and 10.7% for local/regional anesthesia
(P  .08). Other investigators have likewise similar cardiac
morbidity and mortality rates after carotid endarterecto-
my.11,12 Muskett, McGreevy, and Miller11 noted a 6.6%
cardiopulmonary event rate for GA and 0 for regional
anesthesia (P  .3).
This study also confirms the utility of clinical cardiac
risk factors, as described by Eagle and associates, for pre-
diction of adverse postoperative cardiac events. The major
cardiac event rate was 22% for patients with two or more
Eagle risk factors versus only 3.4% for those with one or less
Eagle risk factors. The presence of two or more of these risk
factors has previously been shown to be a marker for
increased cardiac risk after EAAA repair.3
Although LA did not improve cardiopulmonary mor-
bidity and mortality rates in this study, several caveats must
be noted. First, the study was retrospective. Second, the GA
and LA groups were not similar with respect to mean age,
mean number of cardiac risk factors, or mean aneurysm
size. However, on multivariate analysis, only the cardiac
risk factors were statistically significant. Similarly, when the
higher cardiac risk group (two or more Eagle risk factors)
was analyzed separately, no difference was seen in major
cardiac events between GA and LA. Third, some may argue
that the use of midazolam and propofol is not truly LA,
depending on the level of sedation. Data on the cardiovas-
cular effects of propofol are conflicting. Propofol may cause
systemic hypotension from a decrease in systemic vascular
resistance.13 In elderly patients who underwent peripheral
arterial surgery with propofol infusion, Monk et al14 ob-
served up to a 33% drop in cardiac output and a 42%
decrease in systemic vascular resistance.
In this study, several differences were seen in the use of
LA for EAAA repair. Anesthetic and operative times were
significantly shorter in the LA group. The LA group had
less intraoperative fluid requirements. Bettex et al6 similarly
noted lower fluid requirements with LA and less need for
vasopressive support. Furthermore, they noted less need for
ICU stay in patients with LA. In this study, the length of
ICU stay was significantly longer in the LA group.
In conclusion, this study showed no difference in over-
all cardiac and pulmonary morbidity and mortality rates
after EAAA repair in comparison of GA and LA. The overall
major cardiac event rate was 10% and was significantly
higher in patients with two or more cardiac risk factors,
irrespective of the anesthetic used. The overall cardiopul-
monary mortality rate was 3% for GA and 2.8% for LA.
Future comparative studies are needed to address this issue.
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